NetraPharma

NetraPharma is a specialty pharmaceutical company focused on the development and commercialization of innovative ophthalmic products to address significant unmet needs in eye care. Headquartered in Princeton, New Jersey, the company targets ocular surface diseases, including dry eye disease and various inflammatory conditions. NetraPharma utilizes a strategic business model that combines internal research and development with the acquisition of high-potential assets to build a robust clinical pipeline. Led by a team of experienced industry executives with extensive backgrounds in the ophthalmology sector, the company aims to deliver improved clinical outcomes through optimized drug delivery systems and novel formulations. Their lead programs are designed to advance through clinical milestones toward regulatory approval and global commercialization.